ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 67 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $57,000 | -61.7% | 19,873 | -43.4% | 0.01% | -65.0% |
| Q3 2021 | $149,000 | +9.6% | 35,086 | +36.4% | 0.02% | -56.5% |
| Q2 2021 | $136,000 | +40.2% | 25,718 | +23.8% | 0.05% | +48.4% |
| Q1 2021 | $97,000 | +40.6% | 20,778 | 0.0% | 0.03% | +55.0% |
| Q4 2020 | $69,000 | -59.2% | 20,778 | -59.3% | 0.02% | -63.0% |
| Q3 2020 | $169,000 | +21.6% | 51,028 | +24.0% | 0.05% | +14.9% |
| Q2 2020 | $139,000 | +13.0% | 41,148 | +28.6% | 0.05% | -9.6% |
| Q1 2020 | $123,000 | – | 32,006 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 507,191 | $5,107,000 | 0.50% |
| Cormorant Asset Management, LP | 356,600 | $3,591,000 | 0.43% |
| Perceptive Advisors | 558,446 | $5,623,000 | 0.42% |
| NEXTHERA CAPITAL LP | 15,000 | $151,000 | 0.21% |
| EMERALD ADVISERS, LLC | 237,070 | $2,387,000 | 0.11% |
| AUXIER ASSET MANAGEMENT | 17,857 | $180,000 | 0.04% |
| FEDERATED HERMES, INC. | 450,000 | $4,532,000 | 0.01% |
| Nationwide Fund Advisors | 49,473 | $498,000 | 0.00% |
| Catalyst Capital Advisors LLC | 348 | $4,000 | 0.00% |
| DEUTSCHE BANK AG\ | 859 | $8,000 | 0.00% |